Literature DB >> 18566506

Structural basis for the high-affinity binding of pyrrolotriazine inhibitors of p38 MAP kinase.

John S Sack1, Kevin F Kish, Matthew Pokross, Dianlin Xie, Gerald J Duke, Jeffrey A Tredup, Susan E Kiefer, John A Newitt.   

Abstract

The crystal structure of unphosphorylated p38alpha MAP kinase complexed with a representative pyrrolotriazine-based inhibitor led to the elucidation of the high-affinity binding mode of this class of compounds at the ATP-binding site. The ligand binds in an extended conformation, with one end interacting with the adenine-pocket hinge region, including a hydrogen bond from the carboxyl O atom of Met109. The other end of the ligand interacts with the hydrophobic pocket of the binding site and with the backbone N atom of Asp168 in the DFG activation loop. Addition of an extended benzylmorpholine group forces the DFG loop to flip out of position and allows the ligand to make additional interactions with the protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566506     DOI: 10.1107/S0907444908010032

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  3 in total

1.  Cloning, purification, crystallization and preliminary X-ray analysis of the catalytic domain of human receptor-like protein tyrosine phosphatase γ in three different crystal forms.

Authors:  Kevin Kish; Patricia A McDonnell; Valentina Goldfarb; Mian Gao; William J Metzler; David R Langley; James W Bryson; Susan E Kiefer; Brian Carpenter; Walter A Kostich; Ryan S Westphal; Steven Sheriff
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-06-30

2.  Deconstructing nucleotide binding activity of the Mdm2 RING domain.

Authors:  Christina Priest; Carol Prives; Masha V Poyurovsky
Journal:  Nucleic Acids Res       Date:  2010-07-29       Impact factor: 16.971

3.  Metformin decreases bacterial trimethylamine production and trimethylamine N-oxide levels in db/db mice.

Authors:  Janis Kuka; Melita Videja; Marina Makrecka-Kuka; Janis Liepins; Solveiga Grinberga; Eduards Sevostjanovs; Karlis Vilks; Edgars Liepinsh; Maija Dambrova
Journal:  Sci Rep       Date:  2020-09-03       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.